| Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends … DM Merino, LM McShane, D Fabrizio, V Funari, SJ Chen, JR White, ... Journal for immunotherapy of cancer 8 (1), 2020 | 376 | 2020 |
| RNA sequencing of cancer reveals novel splicing alterations J Eswaran, A Horvath, S Godbole, SD Reddy, P Mudvari, K Ohshiro, ... Scientific reports 3 (1), 1-12, 2013 | 221 | 2013 |
| Transcriptomic landscape of breast cancers through mRNA sequencing J Eswaran, D Cyanam, P Mudvari, SDN Reddy, SB Pakala, SS Nair, ... Scientific reports 2 (1), 264, 2012 | 111 | 2012 |
| Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project DM Vega, LM Yee, LM McShane, PM Williams, L Chen, T Vilimas, ... Annals of Oncology 32 (12), 1626-1636, 2021 | 96 | 2021 |
| A scalable solution for tumor mutational burden from formalin- fixed, paraffin-embedded samples using the Oncomine Tumor Mutation Load Assay R Chaudhary, L Quagliata, J Martin, I Alborelli, D Cyanam, V Mittal, ... Translational Lung Cancer Research 7 (6), 616-630, 2018 | 42 | 2018 |
| TMB Harmonization Consortium. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic … DM Merino, LM McShane, D Fabrizio, V Funari, SJ Chen, JR White, ... J Immunother Cancer 8 (1), e000147, 2020 | 18 | 2020 |
| Estimating tumor mutation burden using next-generation sequencing assay. R Chaudhary, J Bishop, A Broomer, D Cyanam, D Mandelman, G Nistala, ... Journal of Clinical Oncology 35 (15_suppl), e14529-e14529, 2017 | 5 | 2017 |
| Alignment of TMB measured on clinical samples: phase IIb of the friends of cancer research TMB harmonization project DM Merino, LM Yee, LM McShane, PM Williams, T Vilimas, R Patidar, ... Cancer Research 80 (16_Supplement), 5671-5671, 2020 | 4 | 2020 |
| Improvement of tumor mutation burden measurement by removal of deaminated bases in FFPE DNA W Tom, R Chaudhary, V Mittal, D Cyanam, I Casuga, E Wong-Ho, ... Cancer Research 79 (13_Supplement), 1701-1701, 2019 | 2 | 2019 |
| Oncomine Knowledgebase Reporter: An information management system to link published evidence with cancer gene variants detected by multivariate tests. S Bandla, D Galimberti, K Kopp, S Anstead, C Zurenko, N Bonevich, ... Journal of Clinical Oncology 34 (15_suppl), e20667-e20667, 2016 | 2 | 2016 |
| Abstract C256: Expanded clinical opportunities for crizotinib from an analysis of over 5,000 cancer patient exomes. S Eddy, M Tomilo, ME Urick, NA Khazanov, P Williams, A Bankhead, ... Molecular Cancer Therapeutics 12 (11_Supplement), C256-C256, 2013 | 2 | 2013 |
| A survey of thousands of tumor exomes and transcriptomes to expand clinical opportunities for crizotinib. E Bowden, S Eddy, P Williams, N Khazanov, A Bankhead, D Cyanam, ... Journal of Clinical Oncology 31 (15_suppl), 11017-11017, 2013 | 2 | 2013 |
| Erratum to" Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project":[Annals of … DM Vega, LM Yee, LM McShane, PM Williams, L Chen, T Vilimas, ... Annals of oncology: official journal of the European Society for Medical …, 2024 | | 2024 |
| Rapid and Automated Comprehensive Genomic Profiling to Assess Single-Gene and Complex Biomarkers Including Genomic Instability M Gupta, Y Jin, E Norris, Y Wang, M Toro, A Phan, Y Zhu, D Wong, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S108-S109, 2023 | | 2023 |
| Fully automated comprehensive genomic profiling for detection of cancer variants, gene fusions, and complex oncology endpoints GM Lowman, D Cyanam, E Norris, M Toro, C Nemes, T Puranik, Y Zhu, ... Cancer Research 83 (7_Supplement), 232-232, 2023 | | 2023 |
| Comprehensive Profiling of Copy Number Changes to Assess Genomic Instability M Gupta, S Sadis, J Kilzer, V Mittal, D Cyanam, Y Jin, G Lowman, ... JOURNAL OF MOLECULAR DIAGNOSTICS 24 (10), S109-S109, 2022 | | 2022 |
| Multifaceted Research Application of Comprehensive Genomic Profiling for Detection of Cancer Variants, Gene Fusions, and Complex Oncology Endpoints D Cyanam, G Lowman, E Norris, J Kilzer, M Toro, J Guo, P Bernardo, ... JOURNAL OF MOLECULAR DIAGNOSTICS 24 (10), S94-S94, 2022 | | 2022 |
| High-throughput next-generation sequencing research solutions for detection of oncology variants, gene fusion events, and key oncology endpoints K Zochowski, D Cyanam, G Lowman, J Kilzer, S El-Difrawy, Y Zhu, ... Cancer Research 82 (12_Supplement), 42-42, 2022 | | 2022 |
| Utilization of a Targeted Next-Generation Sequencing Assay for Assessment of Tumor Cellularity, and Genome-Wide and Gene-Specific Loss of Heterozygosity (LOH) M Gupta, S Sadis, J Veitch, S Bandla, K Conner, D Cyanam, S El-Difrawy, ... JOURNAL OF MOLECULAR DIAGNOSTICS 22 (11), S67-S67, 2020 | | 2020 |
| Comprehensive genomic profiling of solid tumors for key targeted and immuno-oncology biomarkers using Ion Torrent NGS technology on the Oncomine Comprehensive Assay Plus (OCA Plus) V Mittal, J Kilzer, D Cyanam, J Au-Young, S Bandla, G Bee, S El-Difrawy, ... Cancer Research 80 (16_Supplement), 179-179, 2020 | | 2020 |
Vinay MittalThermo Fisher ScientificVerified email at gatech.edu
